Disease diagnostics using machine learning of immune receptors
Biorxiv : the Preprint Server for Biology
|May 13, 2022
Summary
This study introduces Machine Learning for Immunological Diagnosis (Mal-ID), a new framework using immune receptor data to screen for multiple diseases. Mal-ID can detect infections, autoimmune disorders, and vaccine responses, improving clinical diagnosis.
Area of Science:
- Immunology
- Bioinformatics
- Machine Learning
Background:
- Current clinical diagnosis relies on physical exams, history, lab tests, and imaging, often overlooking the immune system's record of antigen exposures.
- The B cell and T cell receptor repertoire encodes a history of immune encounters, offering a potential diagnostic resource.
Approach:
- Developed MAchine Learning for Immunological Diagnosis (Mal-ID), an interpretive framework analyzing immune receptor datasets from 593 individuals.
- Utilized machine learning to screen for multiple illnesses simultaneously or pinpoint specific conditions.
Key Points:
- Mal-ID successfully detects specific infections (e.g., SARS-CoV-2, Influenza, HIV), autoimmune disorders (Systemic Lupus Erythematosus, Type-1 Diabetes), and vaccine responses.
- The model's human-interpretable features align with known immune responses and highlight antigen-specific receptors.
- Demonstrated distinct autoreactivity patterns in Systemic Lupus Erythematosus and Type-1 Diabetes.
Conclusions:
- The Mal-ID framework offers a novel approach to clinical diagnosis by leveraging immunological data.
- This analysis framework has broad potential for scientific and clinical interpretation of human immune responses.
- Mal-ID can screen for multiple conditions or precisely diagnose single diseases, enhancing diagnostic capabilities.


